News & Updates

Show Multimedia Only
Statin use linked to reduced risk of severe COVID-19 outcomes

Statin use linked to reduced risk of severe COVID-19 outcomes

06 Nov 2022 byRoshini Claire Anthony

Patients who are on long-term statin therapy may have a reduced risk of severe COVID-19–related outcomes including mortality, intensive care unit (ICU) admission, and requirement for mechanical ventilation, according to a study presented at Anesthesiology 2022.

Statin use linked to reduced risk of severe COVID-19 outcomes

06 Nov 2022
Alcohol benefits may be overestimated

Alcohol benefits may be overestimated

04 Nov 2022

The benefits of alcohol for cardiovascular disease (CVD) outcomes may have been overestimated by observational studies, according to a recent analysis.

Alcohol benefits may be overestimated

04 Nov 2022
Extended-release nifedipine benefits women with severe pre-eclampsia

Extended-release nifedipine benefits women with severe pre-eclampsia

02 Nov 2022
Hypertrophic cardiomyopathy on the rise

Hypertrophic cardiomyopathy on the rise

02 Nov 2022

In Japan, the prevalence of hypertrophic cardiomyopathy (HCM), regardless of subtype, increased between 2016 and 2020, a recent study has found.

Hypertrophic cardiomyopathy on the rise

02 Nov 2022